A Pilot Study Investigating the Views of Key Stakeholders on Somatic and Germline Cancer Testing
https://www.facingourrisk.org/research-clinical-trials/study/298/individuals-views-on-somatic-and-germline-testing
This is a survey research study enrolling people with a history of cancer, cancer genetic testing, and an inherited mutation or variant of uncertain significance (VUS) in a hereditary cancer gene
About the Study
This study is no longer recruiting patients.
The goal of this study is to explore individuals’ views on somatic and germline cancer testing to inform future studies. This is a 10-15 minute web survey research study enrolling people with a history of cancer, cancer genetic testing, and an inherited mutation or variant of uncertain significance (VUS) in a hereditary cancer gene (e.g., APC, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CDK4, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53).
Lead Researcher
Principal Investigator: Kunal Sanghavi, MBBS, MS, CGC
Senior Program Manager - Genetic Counseling, The Jackson Laboratory for Genomic Medicine
10 Discovery Dr.
Farmington, CT 06032
This Study is Open To:
This study is no longer recruiting patients.
This Study is Not Open To:
This study is no longer recruiting patients.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.